QUVIVIQ

Serial Number 79274313
Registration 6166353
700

Registration Progress

Application Filed
Nov 5, 2019
Under Examination
Approved for Publication
Jul 21, 2020
Published for Opposition
Jul 21, 2020
Registered
Oct 6, 2020

Attorney Assistance

Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20201006)
Due: Oct 06, 2026 294 days

Trademark Image

QUVIVIQ

Basic Information

Serial Number
79274313
Registration Number
6166353
Filing Date
November 5, 2019
Registration Date
October 6, 2020
Published for Opposition
July 21, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 6, 2020
Registration
Registered
Classes
005

Rights Holder

Idorsia Pharmaceuticals Ltd

25
Address
Hegenheimermattweg 91
CH-4123 Allschwil
CH

Ownership History

Idorsia Pharmaceuticals Ltd.

Original Applicant
25
CH-4123 Allschwil CH

Idorsia Pharmaceuticals Ltd.

Owner at Publication
25
CH-4123 Allschwil CH

Idorsia Pharmaceuticals Ltd.

Original Registrant
25
CH-4123 Allschwil CH

Idorsia Pharmaceuticals Ltd

New Owner After Registration #1
25
CH

Legal Representation

Attorney
Mary Margaret L. O'Donnell

USPTO Deadlines

Next Deadline
294 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20201006)
Due Date
October 06, 2026
Grace Period Ends
April 06, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

39 events
Date Code Type Description Documents
Oct 6, 2025 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Aug 22, 2025 RHRD I RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED Loading...
Aug 16, 2024 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Feb 14, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jan 23, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jan 23, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jan 6, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Dec 11, 2020 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 6, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 31, 2020 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jul 21, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 21, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 15, 2020 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jul 15, 2020 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jul 1, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 15, 2020 ALIE A ASSIGNED TO LIE Loading...
Jun 12, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 12, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 12, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 12, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 12, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 23, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 22, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 22, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 22, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 22, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 22, 2020 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
May 22, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 22, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 22, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 21, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 4, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Mar 3, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Feb 9, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Feb 8, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 8, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 24, 2019 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 20, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 19, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, brain haemorrhage and sequelae thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer

Classification

International Classes
005